Ketamine and Psychedelic Research Studies
Committed to ensuring all those suffering from physical or mental health conditions can find lasting relief, Reverie Mind is at the forefront of researching new, novel therapies.
A Focus on Psychedelic-Based Restoratives
Offering hope for sufferers let down by traditional remedies, our psychedelic and ketamine research studies are paving the way for new therapies. Because safety is at the forefront of all we do, we work under the guidance and regulation of the U.S. Food and Drug Administration.
With over 50 combined years of clinical research experience, our team focuses on psychedelic-based research and development. Because of this focus, we're able to offer patients access to novel therapies that may help relieve their treatment-resistant condition.
Approved Studies
Learn More
Schizophrenia
Major Depressive Disorder
Schizophrenia
Major Depressive Disorder
Postpartum Depression
Research Partnership Opportunities
If you're a company developing cutting-edge psychedelic therapies for use in the mental health space, partner with Reverie Mind. We're dedicated to advancing safety and effectiveness research through ketamine clinical trials and look forward to working with like-minded professionals.
Break Free
Go beyond ketamine to find the lasting relief you deserve.
